Cibus Valuation Multiples

Cibus Overview

About Cibus

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Founded

2010

HQ

Employees

159

Website

cibus.com

Sectors

AgricultureBioindustrialsDiagnostics & GenomicsAgriTechBioTechDeepTech

Financials (LTM)

Revenue: $5M

EBITDA: ($74M)

EV

$144M

Valuation Multiples

Multiples.vc

Start free trial

Cibus Financials

Cibus reported last 12-month revenue of $5M and negative EBITDA of ($74M).

In the same LTM period, Cibus generated $5M in gross profit, ($74M) in EBITDA losses, and had net loss of ($110M).

Cibus P&L

In the most recent fiscal year, Cibus reported revenue of $4M and EBITDA of ($83M).

Cibus expects next 12-month revenue of XXX and NTM EBITDA of XXX

Cibus Stock Performance

Cibus has current market cap of $121M, and enterprise value of $144M.

Cibus' stock price is $1.59.

Cibus Valuation Multiples

Cibus trades at 29.9x EV/Revenue multiple, and (1.9x) EV/EBITDA.

Cibus Financial Valuation Multiples

As of April 19, 2026, Cibus has market cap of $121M and EV of $144M.

Equity research analysts estimate Cibus' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cibus has a P/E ratio of (1.1x).

Cibus Margins & Growth Rates

Cibus' revenue in the last 12 month grew by 97%.

Cibus' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.

Cibus' rule of 40 is (604%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cibus' rule of X is (442%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Cibus Public Comps

See public comps and valuation multiples for other Agriculture and Bioindustrials comps.

Cibus M&A Activity

Cibus acquired XXX companies to date.

Last acquisition by Cibus was on XXXXXXXX, XXXXX. Cibus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Cibus Investment Activity

Cibus invested in XXX companies to date.

Cibus made its latest investment on XXXXXXXX, XXXXX. Cibus invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).